UPDATE 1-AstraZeneca hopes to escape drug sales trough in second half
April 27, 2017 at 03:43 AM EDT
* Focus on pivotal lung cancer trial results due mid-year (Adds analyst comment, shares, detail on competitors)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.